Dr Reddys Laboratories (RDY) FCF Margin (2009 - 2026)

Dr Reddys Laboratories has reported FCF Margin for 17 years, with the latest figure at 3.1% in Q2 2026.

• On a quarterly basis, FCF Margin fell 2205.0% year-over-year to 3.1% in Q2 2026; TTM through Jun 2026 was 19.57%, a 123.0% decrease from a year earlier, with the FY2026 full-year figure at 25.34%, up 283.0% from the prior year.
• FCF Margin was 3.1% for Q2 2026 at Dr Reddys Laboratories, down from 23.62% in the prior quarter.
• The five-year high for FCF Margin was 41.58% in Q4 2022, with the low at 3.1% in Q2 2026.
• Average FCF Margin over 5 years is 22.51%, with a median of 22.75% recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: FCF Margin soared 1953 bps in 2022, then plunged 2970 bps in 2023.
• Over 5 years, FCF Margin stood at 41.58% in 2022, then sank by 71 bps to 11.88% in 2023, then jumped by 77 bps to 21.02% in 2024, then grew by 12 bps to 23.62% in 2025, then slumped by 87 bps to 3.1% in 2026.
• The last three FCF Margin figures came in at 3.1% (Q2 2026), 23.62% (Q3 2025), and 25.15% (Q2 2025), per Business Quant data.